Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-08 Sale | 2026-10-09 4:47 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 63,209 | $94.07 | $5,945,855 | 39,218,111 (Indirect Direct) | View |
| 2026-10-07 Sale | 2026-10-07 5:14 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 24,000 | $95.86 | $2,300,633 | 39,281,320 (Indirect Direct) | View |
| 2026-10-05 Sale | 2026-10-06 4:59 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 93,000 | $97.14 | $9,033,642 | 39,305,320 (Indirect Direct) | View |
| 2026-10-01 Sale | 2026-10-02 4:27 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 34,000 | $97.09 | $3,301,069 | 39,398,320 (Indirect Direct) | View |
| 2026-09-29 Sale | 2026-09-30 4:29 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 66,000 | $98.19 | $6,480,659 | 39,432,320 (Indirect Direct) | View |
| 2026-09-25 Sale | 2026-09-28 5:16 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 61,000 | $98.57 | $6,012,500 | 39,498,320 (Indirect Direct) | View |
| 2026-09-23 Sale | 2026-09-24 4:26 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 69,000 | $99.17 | $6,842,742 | 39,559,320 (Indirect Direct) | View |
| 2026-09-21 Sale | 2026-09-22 5:04 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 79,000 | $99.5 | $7,860,757 | 39,628,320 (Indirect Direct) | View |
| 2026-09-17 Sale | 2026-09-18 4:41 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 64,000 | $97.49 | $6,239,071 | 39,707,320 (Indirect Direct) | View |
| 2026-09-15 Sale | 2026-09-16 4:46 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 49,000 | $96.37 | $4,721,976 | 39,771,320 (Indirect Direct) | View |
| 2026-09-11 Sale | 2026-09-14 4:50 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 86,000 | $98.13 | $8,439,336 | 39,820,320 (Indirect Direct) | View |
| 2026-09-10 Sale | 2026-09-11 5:18 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 20,500 | $96.31 | $1,974,287 | 39,906,320 (Indirect Direct) | View |
| 2026-09-08 Sale | 2026-09-09 5:29 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 73,000 | $98.5 | $7,190,663 | 39,926,820 (Indirect Direct) | View |
| 2026-09-03 Sale | 2026-09-08 4:10 pm | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 76,500 | $103.12 | $7,889,055 | 781,709 (Direct) | View |
| 2026-04-22 Sale | 2026-04-23 4:02 pm | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 50,000 | $110.56 | $5,527,960 | 399,387 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-12 Option Award | 2026-05-13 4:09 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Zapata Gomez Ramon Chief Financial Officer | 33,982 | $0 | 33,982 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:07 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Ryan James Timothy Patrick See remarks. | 22,655 | $0 | 22,655 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:05 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 22,655 | $0 | 22,655 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:03 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Jimenez Kylie Chief People Officer | 18,879 | $0 | 18,879 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:02 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Hanekamp Annemarie Chief Commercial Officer | 22,655 | $0 | 22,655 (Direct) | View |
Ownership(A) | 2026-04-13 4:02 pm | N/A N/A | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 0 | $0 | 39,218,111 (Indirect) | View |
Ownership | 2026-03-25 6:03 pm | N/A N/A | BioNTech SE | BNTX | Morawietz Anja Director | 0 | $0 | 240 (Direct) | View |
Ownership | 2026-03-25 6:01 pm | N/A N/A | BioNTech SE | BNTX | Staudigl Rudolf Director | 0 | $0 | 400 (Direct) | View |
Ownership | 2026-03-25 6:00 pm | N/A N/A | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 0 | $0 | 41,162,694 (Indirect) | View |
Ownership | 2026-03-25 5:57 pm | N/A N/A | BioNTech SE | BNTX | Ryan James Timothy Patrick See remarks. | 0 | $0 | 51,629 (Direct) | View |
Ownership | 2026-03-18 5:41 pm | N/A N/A | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 0 | $0 | 678,075 (Indirect) | View |
Ownership | 2026-03-18 5:39 pm | N/A N/A | BioNTech SE | BNTX | Jeggle Helmut Wolfgang Director | 0 | $0 | 989,267 (Direct) | View |
Ownership | 2026-03-18 5:36 pm | 2027-05-22 2033-05-22 | BioNTech SE | BNTX | Tureci Ozlem Chief Medical Officer | 0 | $0 | 86,590 (Direct) | View |
Ownership | 2026-03-18 5:33 pm | N/A N/A | BioNTech SE | BNTX | Wandschneider Ulrich Director | 0 | $0 | 1,927 (Indirect) | View |
Ownership | 2026-03-18 5:30 pm | 2029-05-28 2035-05-28 | BioNTech SE | BNTX | Hanekamp Annemarie Chief Commercial Officer | 0 | $0 | 19,885 (Direct) | View |